Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04010318
Other study ID # 33109/05/19
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 15, 2019
Est. completion date February 11, 2021

Study information

Verified date March 2021
Source Tanta University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

- Full term pregnant female patients presented for elective C.S for single viable fetus will be included in this study. - Before anesthesia, the patient will be attached to a monitor of: ECG , heart rate, non invasive blood pressure, pulse taximeter applied on the index finger of the limb not attached to the blood pressure cuff, pulse oximetry and plethysmographic variability index (PVI) and perfusion index (PI) will be taken by (Massimo radical 7, Massimo corp. USA). Measures will be recorded every 5 minutes preoperative. - Patients with PVI <15 will be excluded from the study. - Patients with PVI > 15 are started on intravenous infusion of warm ringer lactate solution via suitable pore intravenous cannula to reach target of PVI <15 or a total 1 liter of ringer lactate. - The patients in which the PVI is corrected by fluid to level below 15 will be Group (C) or corrected group. Patients in which intravenous fluid administration did not result any change in PVI or changed but still higher than 15 will be Group (NC) or non corrected group. After preoperative preparation patient is shifted to operating theater, with all monitors applied. She will receive spinal block at lumbar 3-4 space with hyperbaric bupivacaine 8 mg plus 25 mic fentanyl. After giving anesthesia and positioning for surgery with a left lateral tilt of 15 degrees,


Description:

- This prospective observational study will be carried out on all pregnant women who will undergo elective cesarean section in obstetric department in Tanta university hospitals under spinal anesthesia over four month duration that starts immediately after obtaining ethical committee approval, an informed written consent will be included with the consent for spinal anesthesia for cesarean section, all patients data will be confidential and will be used for the current study only. - Inclusion criteria: Pregnant women which are listed to undergo elective caeserian section for single viable baby under spinal anesthesia. - Exclusion criteria: - Patients with pregnancy less than 36 weeks or more than 40 weeks - Patients with hypertension , pre-eclampsia , eclampsia. - Patients with diabetes - Patients with cardiovascular disease and /or arrhythmia. - Patients with placenta previa, accreta, percreta. - Obese patients with BMI >36 - Polyhydramnious patients - On arrival of patients to pre-anaesthesia preparation room, we will allow patients to rest in supine position with 15 degree left tilt by pillow wedge under right hip, after allowing patient to rest for five minutes, measures are recorded: ECG , heart rate, non invasive blood pressure, pulse oximeter applied on the index finger of the limb not attached to the blood pressure cuff, pulse oximetry and Plethysmography variability index (PVI) and perfusion index (PI) will be taken by (Massimo radical 7, Massimo corp. USA). Measures will be recorded every 5 minutes preoperative. Patients with PVI <15 are excluded from the study. Patients with PVI > 15 are started on intravenous infusion of warm ringer lactate solution via suitable pore intravenous cannula to reach target of PVI <15 or a total 1 liter of ringer lactate. The patients in which the PVI is corrected by fluid to level below 15 will be Group (C) or corrected group. Patients in which intravenous fluid administration did not result any change in PVI or changed but still higher than 15 will be Group (NC) or non corrected group. After preoperative preparation patient is shifted to operating theater, with all monitors applied. She will receive spinal block at lumbar 3-4 space with hyperbaric bupivacaine 8 mg plus 25 mic fentanyl. After giving anesthesia and positioning for surgery with a left lateral tilt of 15 degrees, supplemental oxygen at rate of 4 liter/minute is applied. Measurements will be taken every minute till delivery of the baby, and if the blood pressure is decreased below 20% of the baseline level before anesthesia, patients will be given incremental doses of ephedrine sulfate 0.1 mg /kg till blood pressure normalized above 80% of pre-anesthesia level. All measurements will be recorded in tables and subjected to statistical analysis.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date February 11, 2021
Est. primary completion date February 11, 2021
Accepts healthy volunteers No
Gender Female
Age group 21 Years to 35 Years
Eligibility Inclusion Criteria: - Pregnant women which are listed to undergo elective caeserian section for single viable baby under spinal anesthesia. Exclusion Criteria: - Patients with pregnancy less than 36 weeks or more than 40 weeks, Patients with hypertension , pre-eclampsia , eclampsia, Patients with diabetes, Patients with cardiovascular disease and /or arrhythmia, Patients with placenta previa , accreta, percreta, Obese patients with BMI >36, or Polyhydramnious patients.

Study Design


Related Conditions & MeSH terms

  • Complication of Anaesthesia During Labour and Delivery
  • Hypotension

Intervention

Procedure:
Spinal Anesthesia
The patients will receive spinal block at lumbar 3-4 space with hyperbaric bupivacaine 8 mg plus 25 mic fentanyl. After giving anesthesia and positioning for surgery with a left lateral tilt of 15 degrees, supplemental oxygen at rate of 4 liter/minute is applied.

Locations

Country Name City State
Egypt Tanta University Hospitals Tanta Algharbia Governate
Egypt Tanta University hospitals Tanta

Sponsors (3)

Lead Sponsor Collaborator
Tanta University Amr Ahmed Magdy, Tamer Mohamed Naguib

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of post-spinal anesthesia hypotension The decrease in the mean arterial pressure below 65 mmHg or below 80% of the baseline value. Through out the whole intraoperative period
Secondary The consumption of vasopressors The total dose of ephedrine required to maintain the MAP above 80% of the baseline value Through out the whole intraoperative period